Christopher Shea to Melanoma
This is a "connection" page, showing publications Christopher Shea has written about Melanoma.
Connection Strength
4.236
-
Update on Thin Melanoma: Outcome of an International Workshop. Adv Anat Pathol. 2016 Jan; 23(1):24-9.
Score: 0.403
-
Melanocytic tumors with intraepidermal melanophages: a report of five cases with review of 231 archived cutaneous melanocytic tumors. J Cutan Pathol. 2015 Jun; 42(6):394-9.
Score: 0.382
-
Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin Dermatol. 2013 Mar-Apr; 31(2):166-78.
Score: 0.331
-
The recurrent nevus phenomenon: a history of challenge, controversy, and discovery. Arch Pathol Lab Med. 2011 Jul; 135(7):842-6.
Score: 0.295
-
Immunohistochemistry of melanocytic proliferations. Arch Pathol Lab Med. 2011 Jul; 135(7):853-9.
Score: 0.295
-
Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol. 2003 Aug; 120(2):203-8.
Score: 0.170
-
CD34 expression in desmoplastic melanoma. J Cutan Pathol. 2001 Nov; 28(10):508-12.
Score: 0.151
-
Maturing papillomatous nevoid melanoma in the scalp mimicking recurrent melanocytic nevus: A case report of previously undescribed subtype of nevoid melanoma. Pathol Int. 2022 Jan; 72(1):59-64.
Score: 0.150
-
Primary chondroid melanoma. J Cutan Pathol. 2001 Oct; 28(9):482-5.
Score: 0.150
-
Malignant melanoma with paradoxical maturation. Am J Surg Pathol. 2000 Dec; 24(12):1600-14.
Score: 0.142
-
Up-Regulation of PARP1 Expression Significantly Correlated with Poor Survival in Mucosal Melanomas. Cells. 2020 05 05; 9(5).
Score: 0.136
-
Recent developments in the pathology of melanocytic neoplasia. Dermatol Clin. 1999 Jul; 17(3):615-30, ix.
Score: 0.128
-
Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas. Hum Pathol. 2018 03; 73:176-183.
Score: 0.116
-
KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas. Br J Dermatol. 2017 Nov; 177(5):1376-1384.
Score: 0.114
-
Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. JAMA Dermatol. 2017 10 01; 153(10):999-1006.
Score: 0.114
-
Scaly erythematous lesion in a patient with extensive solar damage. Malignant melanoma in situ, amelanotic type. Arch Dermatol. 1996 Oct; 132(10):1239, 1242.
Score: 0.106
-
Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group. J Am Acad Dermatol. 2016 Aug; 75(2):356-63.
Score: 0.103
-
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J Cutan Pathol. 2015 Apr; 42(4):244-52.
Score: 0.096
-
Angiotropic metastatic malignant melanoma. Am J Dermatopathol. 1995 Feb; 17(1):58-62.
Score: 0.095
-
Nevus versus melanoma: to FISH, or not to FISH. Adv Anat Pathol. 2011 May; 18(3):229-34.
Score: 0.073
-
Granulomatous eruption after BCG vaccine immunotherapy for malignant melanoma. J Am Acad Dermatol. 1989 Nov; 21(5 Pt 2):1119-22.
Score: 0.066
-
Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol. 2008 Nov; 35 Suppl 2:1-10.
Score: 0.061
-
PAX3 expression in primary melanomas and nevi. Mod Pathol. 2008 May; 21(5):525-30.
Score: 0.059
-
Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Am J Surg Pathol. 2008 Jan; 32(1):36-44.
Score: 0.058
-
Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol. 2006 Nov; 155(5):988-93.
Score: 0.053
-
Angiotropism in epidermotropic metastatic melanoma: another clue to the diagnosis. Am J Dermatopathol. 2006 Oct; 28(5):429-33.
Score: 0.053
-
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901. J Immunother. 2006 Jan-Feb; 29(1):95-101.
Score: 0.050
-
Pagetoid melanocytosis: when is it significant? Pathology. 2004 Oct; 36(5):435-44.
Score: 0.046
-
Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Arch Dermatol. 2002 May; 138(5):603-8.
Score: 0.039
-
Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999 Jul; 23(7):786-94.
Score: 0.032
-
Primary malignant melanoma of the esophagus. J Surg Oncol. 1997 Nov; 66(3):201-6.
Score: 0.029
-
Immunohistochemical expression of retinoblastoma protein in cutaneous melanomas. Br J Dermatol. 1995 Dec; 133(6):890-5.
Score: 0.025
-
p53 expression is rare in cutaneous melanomas. Am J Dermatopathol. 1995 Aug; 17(4):344-9.
Score: 0.024
-
Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995 Jul 01; 55(13):2713-8.
Score: 0.024
-
Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi. J Cutan Pathol. 1994 Oct; 21(5):393-7.
Score: 0.023
-
Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res. 1994 Feb; 4(1):35-45.
Score: 0.022
-
Oncogenes in melanomas. J Dermatol. 1992 Nov; 19(11):853-67.
Score: 0.020